Assessment of pathologic response to neoadjuvant chemotherapy in locally advanced non-small cell lung cancer using FDG-PET/CT: SUVmax versus metabolic tumor volume.
M. Soussan
No relevant relationships to disclose
K. Chouahnia
No relevant relationships to disclose
M. Kambouchner
No relevant relationships to disclose
A. Khafagy
No relevant relationships to disclose
G. Des Guetz
No relevant relationships to disclose
L. H. Zelek
No relevant relationships to disclose
E. Martinod
No relevant relationships to disclose
J. F. Morere
No relevant relationships to disclose